These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 79328)

  • 21. Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. III. Role of the MLC-stimulating cell population in alpha-fetoprotein-induced suppression of T cell-mediated cytotoxicity.
    Peck AB; Murgita RA; Wigzell H
    J Immunol; 1982 Mar; 128(3):1134-40. PubMed ID: 6173421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive properties of mouse amniotic fluid.
    Tyan ML
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):343-7. PubMed ID: 56005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
    Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive activity of bovine seminal plasma on bovine lymphocytes in vitro.
    Fahmi HA; Hunter AG; Markham RJ; Seguin BE
    J Dairy Sci; 1985 Sep; 68(9):2315-21. PubMed ID: 2933433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of alpha-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response.
    Parmely MJ; Thompson JS
    J Immunol; 1976 Nov; 117(5 Pt.2):1832-7. PubMed ID: 62791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
    Yoshida M; Takeuchi M; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive activity of human seminal plasma. I. Inhibition of in vitro lymphocyte activation.
    Lord EM; Sensabaugh GF; Stites DP
    J Immunol; 1977 May; 118(5):1704-11. PubMed ID: 140192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of lymphocyte transformation by disrupted murine oncornavirus.
    Fowler AK; Twardzik DR; Reed CD; Weislow OS; Hellman A
    Cancer Res; 1977 Dec; 37(12):4529-31. PubMed ID: 144563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The number of reactive cells in mouse lymphocyte cultures stimulated by phytohemagglutinin, concanavalin A or histocompatibility antigen.
    Jones G
    J Immunol; 1973 Sep; 111(3):914-20. PubMed ID: 4270195
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphoid procoagulant activity and mitogenesis in the C3H/HeJ mouse: discordant response to lipopolysaccharide stimulation.
    Levy GA; Edgington TS
    J Immunol; 1980 Jun; 124(6):2665-8. PubMed ID: 7373041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of immunosuppressive factor(s) by a weakly immunogenic fibrosarcoma T 241.
    Gautam SC
    Anticancer Res; 1983; 3(4):263-8. PubMed ID: 6224458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide-induced immunomodulation of the generation of cell-mediated cytotoxicity. I. Suppression of the development of cytotoxic lymphocytes.
    Vallera DA; Pflugfelder U; Schmidtke JR
    J Immunol; 1980 Feb; 124(2):635-40. PubMed ID: 6444314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipopolysaccharide-induced immunomodulation of the generation cell-mediated cytotoxicity. II. Evidence for the involvement of a regulatory B lymphocyte.
    Vallera DA; Gamble CE; Schmidtke JR
    J Immunol; 1980 Feb; 124(2):641-9. PubMed ID: 6444315
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of mitogen and allogeneic stimulated lymphocyte growth by human amniotic fluid: lack of correlation between alpha-fetoprotein level and in vitro immunosuppression.
    Wajner M; Papiha SS; Wagstaff TI
    Eur J Obstet Gynecol Reprod Biol; 1986 Apr; 21(4):225-32. PubMed ID: 2423388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoregulatory mechanisms in pregnancy. II. Further characterization of suppressor lymphocytes induced by alpha-fetoprotein in lymphoid cell cultures.
    Toder V; Blank M; Gleicher N; Nebel L
    J Clin Lab Immunol; 1983 Jul; 11(3):149-54. PubMed ID: 6193275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes.
    Mortensen RF; Gewurz H
    J Immunol; 1976 May; 116(5):1244-50. PubMed ID: 131842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte response to phytohaemagglutinin in the presence of serum from pregnant women: correlation with serum levels of alpha-foetoprotein.
    Figueredo MA; Palomino P; Ortiz F
    Clin Exp Immunol; 1979 Jul; 37(1):140-4. PubMed ID: 90571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts.
    Hersh EM; McCredie KB; Freireich EJ
    Clin Exp Immunol; 1974 Jul; 17(3):463-73. PubMed ID: 4283280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Didemnin B: a new immunosuppressive cyclic peptide with potent activity in vitro and in vivo.
    Montgomery DW; Zukoski CF
    Transplantation; 1985 Jul; 40(1):49-56. PubMed ID: 2409649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.